A Comparison Between Octreotide-Lar and Lanreotide-Sr in the Chronic Treatment of Acromegaly

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje.0.1410267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Differing Effects on Gall-Bladder Motility of Lanreotide SR and Octreotide LAR for Treatment of Acromegaly

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Endocrine Abstracts
2016English

Change in Quality of Life in Patients With Acromegaly After Treatment With Octreotide LAR: First Application of AcroQoL in Korea

BMJ Open
Medicine
2015English

Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis

Journal of Oncology Pharmacy Practice
MedicineOncologyPharmacology
2019English

Medical Treatment of Benign Insulinoma Using Octreotide LAR: A Case Report

Endocrine Journal
EndocrinologyMetabolismDiabetes
2007English

Effectiveness and Tolerability of Lanreotide in Acromegaly: A German Database Analysis

Endocrine Abstracts
2015English

Treatment of Recurrent Gastrointestinal Haemorrhage in a Patient With Von Willebrand's Disease With Octreotide LAR and Propranolol

Gut
Gastroenterology
2005English

A Patient With Acromegaly Who Showed Remarkable Improvement of Hyperglycemia After Treatment With Octreotide.

Internal Medicine
Internal MedicineMedicine
1997English

Long-Term Treatment of Acromegaly and Gigantism With Octreotide (SMS 201-995)

Folia Endocrinologica Japonica
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy